Laurentius A. Lesmana , H.Ali Sulaiman , H.M. Sjaifoellah Noer , Fumio Tsuda , Hiroaki Okamoto
{"title":"Hepatitis C virus genotypes and co-infection with GB virus C in patients with anti-HCV-positive chronic liver disease in Jakarta, Indonesia","authors":"Laurentius A. Lesmana , H.Ali Sulaiman , H.M. Sjaifoellah Noer , Fumio Tsuda , Hiroaki Okamoto","doi":"10.1016/S0928-4346(96)00321-0","DOIUrl":"10.1016/S0928-4346(96)00321-0","url":null,"abstract":"<div><p>Of 153 patients with chronic liver disease in Jakarta, Indonesia, who were positive for antibody to hepatitis C virus (HCV), 129 (84%) had HCV RNA in serum. HCV genotypes were II/1b in 55 (43%), III/2a in 33 (26%) and 1c in 15 (12%) patients; genotypes were not classifiable into the common five (I/1a, II/1b, III/2a, IV/2b and V/3a) or 1 c in the remaining 25 (19%) patients. RNA of a putative non-A-E hepatitis virus, designated GB virus C (GBV-C), was tested for by reverse-transcription polymerase chain reaction with nested primers deduced from the 5′-noncoding region, and detected in 18 (12%) patients of whom 14 (78%) possessed serum HCV RNA. These results indicate that 1c and the other indigenous genotypes of HCV, as well as the co-infection with GBV-C, would be common among Indonesian patients with HCV-associated chronic liver disease.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00321-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79854986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats","authors":"Yohei Fukumoto , Keisuke Hino , Mitsuru Yasunaga , Kiwamu Okita","doi":"10.1016/S0928-4346(96)00329-5","DOIUrl":"10.1016/S0928-4346(96)00329-5","url":null,"abstract":"<div><p>Microtubules, which are components of the cytoskeleton, are the organelles involved in vesicular transport. In the hepatocyte, the microtubular network is presumed to be concerned with bile acid secretion, and there may also be some structural changes in cholestatic conditions. The polymerized tubulin levels were determined as microtubules in the liver by the radiochemical assay in rats after the administration of taurocholic acid, colchicine, taurocholic acid following the treatment of colchicine, cytochalasin B and common bile duct ligation. The polymerized tubulin levels were increased after the high dose administration of taurocholic acid, but were decreased after the treatment with colchicine. In cholestasis models induced by cytochalasin B and common bile duct ligation, the polymerized tubulin levels were markedly increased. These findings suggest the microtubule system plays an important role in the excretion of a large amount of bile acids into the bile, and that growth of the microtubular network occurs in cholestasis in order to promote the vesicular transport and to maintain the cell shape.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00329-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74617424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Detection of telomerase activity in hepatocellular carcinoma by fluorescence-based TRAP method","authors":"Hisashi Hisatomi, Yasuko Kawaoto, Yoshimi Ohmura, Miwako Kuwahara, Toshiyasu Yamauchi, Kazumasa Hikiji","doi":"10.1016/S0928-4346(96)00323-4","DOIUrl":"10.1016/S0928-4346(96)00323-4","url":null,"abstract":"<div><p>Telomeres are important for the function and stability of eukaryotic chromosomes. Telomeric DNA is shortened every time liver cells divide. Normal human liver cells have a limited proliferative capacity, but immortalized cells prevent the shortening of the end of chromosomes by the expression of telomerase, the enzyme that elongates telomeric DNA. Although many genetic alterations have been reported in hepatocellular carcinoma, whether all hepatocellular carcinoma are immortalized cells is not known. Therefore, the telomerase activity was analyzed in 38 frozen samples from human hepatocellular carcinoma by fluorescence-based TRAP Method. Telomerase activity was detected in 34 (89.47%) of 38 hepatocellular carcinoma tissues regardless of tumor size, but telomerase activity was detected in only 12 (31.58%) of 38 nontumor liver tissues from patients with hepatocellular carcinoma. Diagnosis of hepatocellular carcinoma is sometimes difficult when the hepatomas are small and are of the differentiated type. Our results showed that the expression of telomerase may be of great value in diagnosing hepatocellular carcinoma.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00323-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74531809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Detection of matrix metalloproteinase gene expression by reverse transcription-polymerase chain reaction in human hepatocellular carcinoma","authors":"Iwata Ozaki, Kyosuke Yamamoto, Toshihiko Mizuta, Yoichi Setoguchi, Fumitaka Morito, Takahiro Sakai","doi":"10.1016/S0928-4346(96)00324-6","DOIUrl":"10.1016/S0928-4346(96)00324-6","url":null,"abstract":"<div><p>Matrix metalloproteinase (MMP) has been reported to play an important role in the process of tumor development and metastasis through the alterations of cell-cell and/or cell-extracellular matrix interactions. We studied the gene expression of matrix metalloproteinase MMP-2 and MMP-7, and also TIMP-1, one of the inhibitors of metalloproteinase, in the tissue of human hepatocellular carcinoma by using semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) method. MMP-2 and MMP-7 have been expressed in advanced hepatocellular carcinomas as well as in non-cancerous, chronically diseased liver tissue, and the expression levels of these MMPs in human hepatocellular carcinoma (HCC) tissues were greater than that of non-cancerous tissues. This data suggests that MMP-2 and MMP-7 may be involved in the process of the development, invasion and metastasis of HCCs.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00324-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85364147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"GB virus C infection in fulminant and acute hepatitis","authors":"Kojiro Michitaka , Norio Horiike , Toshikazu Masumoto , Fazle S.M. Akbar , Naofumi Ohno , Morikazu Onji","doi":"10.1016/S0928-4346(96)00322-2","DOIUrl":"10.1016/S0928-4346(96)00322-2","url":null,"abstract":"<div><p>To assess the presence of GB virus C (GBV-C) in fulminant and acute hepatitis, GBV-C-RNA was screened by reverse transcription-polymerase chain reaction (RT-PCR) in sera from 33 patients with acute and subacute liver diseases (fulminant hepatitis 14, late onset hepatic failure 2, acute hepatitis 17). GBV-C was detected in two of 14 patients with fulminant hepatitis, but not in any patient with acute hepatitis and late onset hepatic failure. Both GBV-C-positive patients were also infected with hepatitis B virus and both of them had a history of blood transfusion. None of the 15 patients with non-A, non-B, non-C (non-A-C) hepatitis were positive for GBV-C. From these data, it is suspected that infection of GBV-C is not very frequent in patients with non-A-C acute and fulminant hepatitis, and that blood transfusion is one of the important routes for GBV-C transfection, which correlates with the relatively high prevalence of patients co-infected with GBV-C and other blood-transmissible viruses such as hepatitis B and C virus.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00322-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88615307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fluorescence-labeled-hyaluronan loading test as an index of hepatic sinusoidal endothelial cell function in the rat","authors":"Hitomi Nakabayashi, Hiroyuki Tsujii, Yasuyuki Okamoto, Hiroshi Nakano","doi":"10.1016/0928-4346(96)00318-0","DOIUrl":"10.1016/0928-4346(96)00318-0","url":null,"abstract":"<div><p>Hyaluronan is an endogenous glycosaminoglycan whose clearance from plasma takes place mainly in the liver sinusoidal endothelial cells. Elevated levels of serum hyaluronan have been reported in various chronic liver diseases. This phenomenon may be caused by the impaired degradation of hyaluronan in damaged liver endothelial cells and also the enhanced production in proliferated connective tissue of the liver. The aim of this investigation was to evaluate the function of uptake of the exogenously administered hyaluronan from blood in the chronically injured liver of rats. We examined plasma clearance of fluorescein amine-labeled hyaluronan and its localization and accumulation in the liver. Plasma clearance of hyaluronan became slower with severity of chronic liver injury. Fluorescence localized in sinusoids was markedly reduced and the accumulation of fluorescence in the liver tissue was significantly decreased in the cirrhotic liver compared with the control liver. These results suggest that, in chronic liver injury, the impaired clearance of hyaluronan from blood is attributed to decreased hyaluronan uptake in the liver.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00318-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77767595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunohistochemical study of expression of p-glycoprotein and mutant p53 protein in hepatocellular carcinoma from the viewpoint of modulation of transcriptional activity of MDR1 gene","authors":"Mariko Itsubo, Gotaro Toda","doi":"10.1016/0928-4346(96)00314-3","DOIUrl":"10.1016/0928-4346(96)00314-3","url":null,"abstract":"<div><p>Recently, it was reported that the promoter region of the human MDR1 gene was a target for the p53 tumor suppressor gene product; a mutant p53 specifically stimulated the MDR1 gene promoter. To elucidate how both proteins, <em>p</em>-glycoprotein and mutant p53 protein, correlate with each other in a human carcinoma cell of HCC in vivo, the expression of these proteins was investigated immunohistochemically. The results from 42 cases of HCC revealed that 28 cases (66.7%) had <em>p</em>-glycoprotein and 12 cases (28.6%) had mutant p53 protein. Regarding the positivity rate of each protein in each histologic differentiation, that of <em>p</em>-glycoprotein was higher in well or moderately differentiated grade than in poorly differentiated grade, whereas that of mutant p53 protein was lower in well or moderately differentiated grade. The distribution of each protein-positive cell was not always uniform through the tumor sections, and the locations of <em>p</em>-glycoprotein-positive carcinoma cells and mutant p53 protein-positive carcinoma cells were poorly coincident in the serial sections of the same case. It seems that p53 protein may not directly affect the expression of <em>p</em>-glycoprotein, therefore <em>p</em>-glycoprotein overexpression in HCC could not be explained only by the direct correlation between mutational inactivation of p53 and stimulation of transcriptional activity of MDR1 gene.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00314-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91082993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Sasaki , M. Sata , H. Suzuki , Y. Uchimura , S. Murashima , K. Tanaka , N. Uchimura , J. Nakamura , M. Ishibashi , K. Tanikawa
{"title":"Change in cerebral blood flow in an acute hepatitis C patient with depressive state while receiving interferon","authors":"M. Sasaki , M. Sata , H. Suzuki , Y. Uchimura , S. Murashima , K. Tanaka , N. Uchimura , J. Nakamura , M. Ishibashi , K. Tanikawa","doi":"10.1016/0928-4346(96)00311-8","DOIUrl":"10.1016/0928-4346(96)00311-8","url":null,"abstract":"<div><p>Regional cerebral blood flow (rCBF) was measured with single photon emission computed tomography (SPECT) using <em>N</em>-isopropyl-<em>p</em>-[<sup>123</sup>I] iodoamphetamine (<sup>123</sup>I-IMP) in a patient with acute hepatitis C who showed depressive state during interferon therapy. During his depressive state the rCBF was decreased markedly in the inferior frontal cortex. This case suggests that psychotic symptoms during IFN therapy may result from decreased rCBF.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00311-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91280885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Involvement of retinoblastoma protein in dibutyryl cyclic AMP-induced growth inhibition of the human hepatoma cells PLC/PRF/5","authors":"Yasuyuki Okamoto , Masaji Kikukawa , Hiroshi Nakano","doi":"10.1016/0928-4346(96)00315-5","DOIUrl":"10.1016/0928-4346(96)00315-5","url":null,"abstract":"<div><p>The role of retinoblastoma (RB) protein in cyclic AMP (cAMP)-induced growth inhibition was investigated with the human hepatoma cells PLC/PRF/5 in culture. Dibutyryl cAMP (DBcAMP) inhibited DNA synthesis of the PLC/PRF/5 cells, and this DBcAMP-induced growth inhibition was partially abrogated by addition of antisense oligodeoxynucleotides (ODN) to RB mRNA. The antisense ODN itself had no significant effect on the growth. DBcAMP also inhibited the phosphorylation of RB proteins. These findings suggest that RB is a mediator of the DBcAMP-induced growth inhibition of PLC/PRF/5 cells.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00315-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81798667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hepatocyte canalicular transport of organic anions in bile duct-ligated rats","authors":"Yukinhiko Adachi , Hirohisa Miya , Yoshifumi Okuyama , Toshinori Kamisako , Toshio Yamamoto","doi":"10.1016/0928-4346(96)00317-9","DOIUrl":"10.1016/0928-4346(96)00317-9","url":null,"abstract":"<div><p>Transport of various intrinsic and extrinsic organic anions across the canalicular membrane of hepatocytes has been confirmed to occur via ATP-dependent primary active transport. To investigate these processes in the presence of obstructive jaundice, the uptake of radiolabeled taurocholate and pravastatin, a non-bile acid organic anion, by isolated hepatocyte canalicular membrane vesicles was observed after bile duct ligation in rats. The Mg<sup>+ +</sup>-ATPase and Na<sup>+</sup>, K<sup>+</sup> -ATPase activity did not differ between membrane vesicle preparations from sham-operated and bile duct-ligated rats. Taurocholate uptake decreased significantly to 45% and 29%, while pravastatin uptake decreased to 35% and 35% of that in sham-operated rats at 2 and 7 days after bile duct ligation. These results indicate that the ATP-dependent transport systems for both bile salts and non-bile acid organic anions are impaired soon after the onset of obstructive jaundice.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1996-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00317-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85949882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}